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Abstract: The world of dentistry is approaching graphene-based nanomaterials as substitutes for
tissue engineering. Apart from its exceptional mechanical strength, electrical conductivity and thermal
stability, graphene and its derivatives can be functionalized with several bioactive molecules. They can
also be incorporated into different scaffolds used in regenerative dentistry, generating nanocomposites
with improved characteristics. This review presents the state of the art of graphene-based nanomaterial
applications in the dental field. We first discuss the interactions between cells and graphene,
summarizing the available in vitro and in vivo studies concerning graphene biocompatibility and
cytotoxicity. We then highlight the role of graphene-based nanomaterials in stem cell control, in terms
of adhesion, proliferation and differentiation. Particular attention will be given to stem cells of dental
origin, such as those isolated from dental pulp, periodontal ligament or dental follicle. The review then
discusses the interactions between graphene-based nanomaterials with cells of the immune system;
we also focus on the antibacterial activity of graphene nanomaterials. In the last section, we offer our
perspectives on the various opportunities facing the use of graphene and its derivatives in associations
with titanium dental implants, membranes for bone regeneration, resins, cements and adhesives as
well as for tooth-whitening procedures.
Keywords: graphene; nanomaterials; dental stem cells; antibacterial activity; dental implant;
bone regeneration
1. Introduction
Tissue engineering is an interdisciplinary science which aims at developing biological substitutes
to restore, maintain, or improve tissue function by using a combination of cells, scaffolds and suitable
biochemical factors [1]. Scaffolds in particular represent the key element in tissue engineering research,
whose role is not only to provide the appropriate environment for specific cells but also to retain
growth and nutrition factors for cellular migration, adhesion, growth and differentiation [2].
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Over the years, several natural and synthetic three-dimensional (3D) scaffolds have been
successfully developed and employed for various tissues, such as skin [3], cartilage [4], muscle [5],
vasculature [6] and bone [7]. With regard to dental tissues, regeneration is very challenging and requires
thorough understanding of biological events at the cellular and molecular level [8]. Tooth indeed is one
of the most difficult tissues to treat due to its heterogeneous and dynamic anatomical structure which
includes the vital dentin-pulp complex, cementum, periodontal ligament, alveolar bone and enamel [9].
Furthermore, dental tissues show a limited and variable degree for self-repair as a result of injury or
disease: cementum, for example, has a very slow regenerative capacity, whereas enamel regeneration
is not possible. Dentin can regenerate, while dental pulp has a partial regeneration capacity as it
is enclosed in dentin and has limited apical blood supply. In contrast, alveolar bone exhibits rapid
turnover in response to mechanical stimulation [10].
In the last decade, many advances have been made in the dental tissue engineering field aimed
at the regeneration of dental pulp [11], periodontal ligament [12,13], dentin [14], enamel [15] and
integrated tooth tissues [16,17], which have seen the interplay of stem cells, growth factors and scaffolds.
Scaffolds including collagen [18], polymers [19], self-assembling peptides [20], or silk [21] have been
used for dental tissues regeneration. A novel strategy that may improve the success of scaffold therapy
is represented by nanosized materials [22]. Nanomaterials possess exciting physicochemical and
biological properties for biomedical applications due to their small size, large surface area and ability
to interact with cells, promoting their adhesion, migration, proliferation and differentiation [23].
In the last few years, graphene and its derivatives have emerged as a new class of nanomaterials [24].
Graphene is a carbon-based flat monolayer, arranged in a two-dimensional hexagonal structure, with
unique mechanical, electrochemical and physical properties. The graphene family nanomaterials include
several graphene derivatives, such as Few-Layered Graphene (FLG), ultrathin graphite, Graphene Oxide
(GO), reduced Graphene Oxide (rGO) and graphene nanosheets [25]. These differ from each other in terms
of surface properties, number of layers and size. In addition to the above graphene derivatives, graphene
family also comprises graphene-based composites, which derive from functionalization of graphene with
polymers, small molecules, or nanoparticles through covalent or noncovalent interactions [26] (Figure 1).
Graphene surface functionalization with molecules of diverse nature allows the development of different
devices, that can enhance or alter the properties required for specific application.
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Figure 1. Schematic representation of different graphene-based nanomaterials. (a) Few-Layered
Graphene (FLG), (b) Graphene Oxide (GO), (c) graphene nanosheets and (d) reduced Graphene Oxide
(rGO) belong to the graphene derivatives group; (e) GO nanoparticle composite and (f) GO polymer
composite are composites of graphene. Reproduced with permissions from [25,26].
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Since its discovery in 2004 [27], many applications have been explored for graphene, ranging from
electronic and optoelectronic devices to photoconductive materials. However, only in 2008 graphene
was introduced for the first time in the field of biomedical sciences [28] and widely used in biomedical
applications such as bioelectronics, bioimaging, drug delivery and tissue engineering [24].
The present review intends to provide the reader an overview of the current state of the art
of the graphene-based nanomaterials in tissue engineering in dentistry. Different aspects of the
graphene-based nanomaterials will be discussed in detail. First, we highlight the role of stem cells
and their interactions with graphene nanomaterials. We consider the influence of graphene-based
nanomaterials both on biocompatibility, cytotoxicity and differentiation properties of stem cells.
In this context, particular attention will be given to stem cells of dental origin. The interactions
with immune cells and antibacterial properties of graphene, which are critical aspects to consider
in the hostile environment of the oral cavity, are subsequently discussed. Finally, applications of
graphene-based nanomaterials on dental implants, membranes, resins, cements and adhesives as well
as on teeth-whitening are extensively presented.
2. Graphene-Based Nanomaterials and Interactions with Cells
The first aspect to consider when developing a new nanomaterial for biomedical applications is its
biocompatibility. Excellent biocompatibility is indeed essential in order to avoid any adverse effect of
a material in living tissues [29]. Apart from being biocompatible, scaffolds should direct the successful
transformation of stem cells into cells and tissues with morphological features and physiological
functions similar to those in vivo. In other words, tissue engineering techniques can be considered
efficient when they obtain stem cell differentiation into the desired tissue lineage [30]. Furthermore,
an ideal scaffold should not evoke an inflammatory response and desirably inhibit bacterial growth on
the surfaces. This feature is very critical when considering the environment of the oral cavity, which is
known to be an important site for bacterial biofilm formation. In the following paragraphs, the effects
of incorporation of graphene-based nanomaterials into different scaffolds, in relation to the issues
described above, will be discussed in detail.
2.1. Graphene Biocompatibility In Vitro and In Vivo
Graphene-based nanomaterials are rapidly spreading as scaffolds in tissue engineering applications,
also in the dental field; consequently, assessments of their biocompatibility and cytotoxicity have to be
done. Dosages, viability assays, type of nanomaterials, type of cells and uses need to be evaluated
before developing a new reliable graphene-based nanomaterial.
Over the years, biocompatibility of graphene and its derivatives has been largely discussed
among authors. The comprehension of the toxicological potential of graphene-based nanomaterials,
indeed, has to be carefully evaluated in order not to interrupt future in vivo studies and translational
efforts [31]. Accumulating evidence suggests that the cytotoxicity of graphene and its derivatives
is influenced by numerous factors, such as their concentration, shape, size, dispersibility, surface
functionalization and that the common mechanisms describing the cytotoxicity of graphene-based
nanomaterials include Reactive Oxygen Species (ROS) production and cell membrane damage [32,33].
The 3-(4,5-Dimethylthiazol-2-yl)-2, 5-Diphenyltetrazolium bromide (MTT) assay, which measures
the mitochondria function of the cells, is one of the preferred method for evaluating the effect of
nanomaterials in cell culture [34]. In one of the pioneering works, the in vitro toxicity of FLG sheets
was compared to that of Single Wall Carbon Nanotubes (SWCNT) by using neuronal PC12 cells [32].
The authors found that the toxicity of these two nanomaterials of relatively identical chemical structure
was concentration-dependent, but, interestingly, these showed a different pattern of toxicity. FLG sheets
resulted more toxic than SWCNT at low concentrations; whereas at higher concentrations graphene
showed a lower activity, thus reversing its cytotoxic effect. These results can be primarily explained by
the different shape of graphene sheets and SWCNT. Indeed, apart from concentration, the shape of
Nanomaterials 2018, 8, 349 4 of 31
nanomaterials plays an extremely important role, determining how these interact with cells and with
potentially other biological systems.
Shortly after, another work evaluated the toxicity and biocompatibility of GO to human lung
A549 cells, a widely used cell line for toxicity studies [33]. Compared to the previous study, the authors
found that GO has much lower toxicity, as indicated by the results of the viability assay and
Lactate Dehydrogenase (LDH) leakage assay. Together with MTT, the LDH assay, which measures
enzyme release resulting from membrane damage, is another reliable and widely accepted test for
evaluating materials toxicity [35]. The results of this work can be explained assuming that the
cytotoxicity of nanomaterials is also heavily influenced by their surface functionalization. In this case,
GO functionalization is higher than that of FLG sheets due to the presence of oxygenated functional
groups. GO is indeed the oxidized derivative of graphene, produced by the oxidation of bulk graphite
powders via chemical oxidation processes. It contains several reactive oxygen functional groups,
such as epoxide, carboxyl and hydroxyl groups, which stabilizes the GO sheets on water, thus making
them more hydrophilic [36].
Another work that stresses this concept is the one by Sasidharan and colleagues [37]. They found
that, while pristine graphene accumulated on the cell membrane causing high oxidative stress
leading to apoptosis, hydrophilic functionalized graphene, although internalized by the cells, did not
cause any toxicity. The potential cytotoxicity of graphene-based nanomaterials is, therefore, highly
dependent on their functionalization degree, as also established in the study of Das and coworkers [38].
When comparing the toxicity of GO and rGO, the first was found to be more toxic than rGO of same
size on all the three cell lines used in the study. rGO is the reduced form of graphene; it is mainly
produced to restore the electrical conductivity and optical absorbance of GO while reducing the oxygen
content, surface charge and hydrophilicity [39]. Authors supposed that cytotoxicity was mediated
by inducing ROS generation in the cells and that the presence of more reactive functional groups of
GO would have a greater potential to interact with biological macromolecules compared with rGO.
Nevertheless, by decreasing extent of oxygen functional group density on the GO surface, it was
possible to reduce oxidative stress and consequently the nanomaterials toxicity.
The physicochemical mechanism of the oxidation-state dependent cytotoxicity of GO was
proposed recently by the group of Zhang [40]. They synthesized three GO samples with similar
size distribution and solubility in water, but with different oxidation state; these samples were then
tested on Mouse Embryo Fibroblasts (MEFs). First of all, their results suggested that 50 µg/mL may be
a threshold for GO to exhibit toxicity on normal mammalian cells. Then, they found that the GO with
lower degree of oxidation displayed stronger toxicity on MEFs and stimulated higher intracellular
ROS production (Figure 2a). As resulted from Electron Spin Resonance (ESR) spectrometry analysis,
the decrease in the oxidation state was correlated to a higher ability of the GO samples to promote
H2O2 decomposition and ·OH formation. Among various types of ROS, ·OH is an extremely reactive
free radical and indiscriminately induces oxidative damages on various biomolecules, including DNA,
lipids and proteins [41].
Soon after, another distinct process contributing to the molecular basis of graphene cytotoxicity
was unraveled by Duan and colleagues [42]. They demonstrated that GO nanosheets were responsible
to induce pore formation on cell membranes. Molecular dynamics simulations revealed that the
molecular mechanism for perforation was dependent on cooperative lipid extraction driven by several
graphene nanosheets (Figure 2b).
With regard to in vivo experiments, there are few studies concerning the biocompatibility of
graphene-based nanomaterials since most of the investigations have only focused on the in vitro aspect
of research. Nevertheless, the in vitro cell culture environment is definitely different from the in vivo
complex 3D physiological condition. In addition, typical cytotoxicity assays measure the effect only
during the first 12–24 h after exposure to a toxic substance although many biological reactions in vivo
continue beyond 24 h.
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(a) Transmission Electron Microscopy (TEM) images of Mouse Embryo Fibroblasts (MEFs) treated
with GO-high (GO-h), GO-medium (GO-m) and GO-low (GO-l) at 50 µg/mL for 24 h. On bottom,
high-magnification images of the boxed-in photos on top are represented. The white and black arrows
indicate GO aggregates inside and outside cells, respectively. (b) Scanning Electron Microscopy (SEM)
images of cell membrane damage incurred by A549 cells as a result of GO nanosheets exposure
observed during different phases of incubation. On bottom, high-magnification images of the boxed-in
photos on top are represented. Reproduced with permissions from [40,42].
As for in vitro experiments, the in vivo effects of graphene-based nanomaterials were observed
to be dependent on their concentration, physicochemical properties, exposure time, but also on
administration route and on the characteristics of the animals used in the assays [43].
Wang and colleagues observed that intravenous injection of GO at 0.1 mg and 0.25 mg showed no
obvious toxicity to mice, whereas almost half animal population died after administration of 0.4 mg
GO [44]. All deaths occurred within days after injection of the GO. When investigating the effects of
GO on organs of mice, the authors determined that graphene-based nanomaterials mainly accumulate
in liver, spleen and lung after intravenous injection.
In another study, GO or pluronic-dispersed graphene was administered by intratracheal
instillation to mice [45]. The authors found that GO induced acute lung injury that persisted for
more than 21 days after administration. Lung inflammation was attributed to GO ability to increase
the rate of mitochondrial respiration and the generation of ROS in cells, activating inflammatory
and apoptotic pathways. On the contrary, toxicity was significantly reduced when the unoxidized
graphene was well-dispersed with the block copolymer pluronic. These results demonstrate that
graphene oxidation contributes to its pulmonary toxicity, whereas dispersion of pristine graphene in
pluronic represents a safe way for handling and potential biomedical application of graphene.
Later, the group of Yang tested several Polyethylene Glycol (PEG) functionalized GO materials
with varied sizes and surface chemistry after oral and intraperitoneal injection to mice [46]. The authors
observed that few h after being administered by oral route, PEGylated GO derivatives were present
in high quantities in stomach and intestine, but not in other major organs. However, only low levels
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were detected in the organs after 1 day and no trace was detected after 1 week. In contrast, high
accumulation of PEGylated GO derivatives was observed in the liver and spleen after intraperitoneal
injection, but their levels gradually decreased.
Considering certain inconsistencies and contradictory results in several studies, generalizations
about graphene toxicity should be avoided. Indeed, it is generally accepted that the in vitro and
in vivo behaviors of graphene-based nanomaterials are closely associated with their physicochemical
properties, such as surface functionalization, coating, size and importantly, the administration routes.
However, based on the studies presented in this section, we may summarize that the hydrophobic
forms of graphene-based nanomaterials, which accumulate on the surface of cell membranes, are more
toxic compared to the most hydrophilic ones. These, in fact, are more prone to infiltrate the cell
membrane and to be internalized, as well as being removed from the application site. At the same
time, when comparing GO with its reduced counterpart, rGO, the latter results less toxic than the
hydrophilic form. Anyway, by controlling the GO reduction and maintaining the solubility, it is
possible to minimize the GO toxicity and unravel the wide range of biomedical applications.
2.2. Graphene, Stem Cells and Osteogenesis
As mentioned before, one of the key characteristics of the ideal scaffold is an effective and
controlled guidance of the proliferation and differentiation of stem cells into specific tissue lineages,
either in the absence or presence of chemical inducers and growth factors. In the past few years,
graphene-based nanomaterials have been increasingly used as scaffold materials for stem cell growth
and differentiation. In the specific field of dental tissue engineering, most of the studies focused
on evaluating the role of graphene in driving the osteogenic differentiation of stem cells. Indeed,
bone regeneration plays a fundamental role in regenerative dentistry and how incorporation of
graphene-based nanomaterials can enhance osteoconductivity through stimulating both cellular
osteogenic differentiation and biomineralization have been extensively investigated [24].
In one of the first in vitro studies using stem cells, graphene produced by the Chemical Vapor
Deposition (CVD) method and combined with different substrates was found to increase human
Mesenchymal Stem Cells (MSCs) proliferation with no signs of cytotoxicity [47]. MSCs are one
of the major progenitor cells achievable from a number of sources including adipose tissue, bone
marrow and dental tissues [48]. Remarkably, graphene-coated scaffolds not only supported the growth
and proliferation of human MSCs, but also accelerated their specific differentiation into osteoblasts,
based on the level of the osteogenic marker osteocalcin and calcium mineralization level. The observed
phenomena were obtained in the absence of additional growth factors and the acceleration rate was
similar to that achieved with the use of typical osteogenic growth factors.
Starting from these results, another group investigated whether the graphene-induced
osteogenesis of human MSCs was correlated to the chemical properties of graphene [49]. In the
study, the effects of graphene and GO substrates were explored on both the osteogenic and adipogenic
differentiation of human Bone Marrow MSCs (BM-MSCs). The results of the work revealed the ability of
graphene to induce BM-MSCs differentiation into osteoblasts, probably by acting as a pre-concentration
platform for dexamethasone and beta-glicerophosphate, typical osteogenic differentiation factors.
In contrast, adipogenic differentiation resulted suppressed on graphene but strongly enhanced on
GO substrates. In this case, the authors hypothesized that GO possesses high adsorption capacity of
insulin, the key mediator for fatty acid synthesis.
Other studies have further tested the effects of GO on MSCs growth and osteogenic differentiation
and the results varied. In the interesting work of Wei and colleagues, the authors compared the
cellular behaviors of BM-MSCs towards pristine GO nanosheets using two in vitro biomimetic culture
methods, that imitate similar situations in vivo [50]. The sequential-seeding method would mimic the
interaction between GO and established cells, whereas the co-seeding method resembles the interaction
between GO and migrating cells. The authors found that both cell proliferation and differentiation
were dependent on pristine GO nanosheets concentration and in vitro culture methods. In particular,
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BM-MSCs cultured with the sequential-seeding method resulted less vulnerable than those cultured
with the co-seeding method, in which the cells had not yet adhered to the substrate. This seeding
approach was beneficial for cells adhesion and proliferation when treated with 0.1 µg/mL of GO.
Analogously, differentiation into osteoblasts was efficiently promoted when BM-MSCs were treated
with this GO concentration, but only when osteogenic inducers were added to culture media (Figure 3a).
In recent years, also 3D graphene-based scaffolds have been actively explored and developed
for the growth and differentiation of stem cells. The group of Crowder was the first to employ 3D
graphene foams as substrates for human BM-MSCs culture [51]. When seeded onto these foams
for 7 days, BM-MSCs were shown to maintain viability; in addition, the cells strongly expressed
the osteogenic markers Osteocalcin (OCN) and Osteopontin (OPN), indicating their spontaneous
osteogenic differentiation without the need for extrinsic biochemical factors (Figure 3b). It could be
assumed that 3D graphene foams provided in vivo-like microenvironments which were conducive for
the differentiation of stem cells.
Besides being used in their pristine form, graphene nanomaterials have also been combined
with different polymers, nanofibers, or nanoparticles to create novel composites for controlling the
growth and differentiation of stem cells. Hydroxyapatite (HAp), for example, is a calcium phosphate
ceramic commonly used for bone repair or regeneration due to its chemical similarity to that of natural
apatite in bones [52]. The recent work of Lee and colleagues demonstrated that rGO-coated HAp
nanocomposites directed spontaneous differentiation of the murine preosteoblastic MC3T3-E1 cells
towards bone lineage even in the absence of osteogenic differentiation factors [53]. Nevertheless,
the osteogenic activity mediated by the rGO-coated HAp composites was further enhanced when these
agents were added to the culture medium (Figure 3c). The authors concluded that, as the rGO-coated
HAp composites showed to be potent inducers of spontaneous osteogenic differentiation of human
MSCs, their application in the orthopedic and dental field may be determinant.
Natural bone is a composite material in which inorganic HAp nanocrystals are orderly embedded
in an organic matrix made of collagen [54]. Collagen sponges are clinically approved scaffolds for bone
regeneration [55]. These provide soft microenvironment to MSCs; however, stem cells preferentially
differentiate to osteogenic lineage when cultured on mechanically stiff substrates. In order to overcome
this problem, the group of Kang modified collagen sponge scaffolds by covalently incorporating GO
flakes [56]. The covalent conjugation of GO flakes to collagen scaffolds increased the scaffold stiffness,
which was comparable to that of pre-mineralized bone matrix and did not cause cytotoxicity of human
MSCs. Importantly, when compared to non-modified collagen scaffolds, the GO-collagen sponges
significantly enhanced the osteogenic differentiation of the cells. The authors hypothesized that the
enhanced osteogenic differentiation was likely mediated by MSCs mechanosensing, since molecules
that are involved in cell adhesion to stiff substrates, such as focal adhesions and cytoskeletal proteins,
were either up-regulated or activated. In a following work of Nishida and coworkers [22], the effect
of GO incorporation into 3D collagen sponges was examined in vitro and in vivo and compared
to that observed with untreated collagen scaffolds. A previous study of the same group revealed
clear morphological changes of collagen scaffolds after GO coating, that were dependent on GO
concentration [57]. Notably, GO coating did not alter the porous structure of collagen sponges but
reinforced their stability. Also, in their following work, the authors found that GO application
improved the physical properties of collagen scaffold, such as compressive strength, enzyme resistance
and adsorption of calcium and proteins. In addition, when GO scaffolds were implanted into a
dog tooth extraction socket, the rate of new bone formation was higher than in the control group
consisting of untreated collagen scaffolds, where most of the socket area was filled by connective tissue.
These results were obtained by means of histomorphometric measurements and radiographic images
taken 2 weeks after implantation.
Among others available materials, peptides containing the repeating arginine-glycine-aspartic
acid (RGD) sequence, which is often found in Extracellular Matrix (ECM) proteins, have been widely
applied to enhance cell adhesion to synthetic polymers or metallic surfaces [58,59]. In one of the
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latest studies, a 3D graphene/RGD peptide nanoisland composite was developed and tested on the
osteogenesis of human Adipose-Derived Stem Cells (ADSCs) [60]. Human ADSCs represent excellent
candidates being accessible for autologous transplantation and able to differentiate into osteogenic
lineage for bone regeneration [61]. Also, in this work beta-glicerophosphate, dexamethasone and
ascorbic acid were added to the culture medium for induction of osteogenesis. Such scaffolds were
found to accelerate ADSCs osteoblastic differentiation, as revealed by gene expression results, Alkaline
Phosphatase (ALP) activity measurements and evaluation of calcium deposition over a period of
4 weeks. Thus, the combination of RGD-containing peptides and GO substrates enhanced the adhesion
strength of stem cells, ultimately resulting in increased osteogenic differentiation, as cell adhesion
is the first step driving osteogenic lineage commitment. Taken together, the results of these studies
would suggest that nanomodifications of different scaffolds using GO might provide good structure
for colonization by several cell types.Nanomaterials 2018, 8, x FOR PEER REVIEW  9 of 30 
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Figure 3. Effect of graphene-based nanomaterials on the osteogenic differentiation of Mesenchymal
Stem Cells (MSCs). (a) Evaluation of matrix mineralization by means of Alizarin Red S (ARS)
staining (top panel) and quantification (bottom panel). MSCs were grown for 21 days in osteogenic
differentiation medium on GO nanosheets. The level of mineralization in the 0.1 µg/mL GO group
was significantly higher than the other two conditions. (b) Human BM-MSCs cultured on 3D
graphene foams for 4 days show protrusions up to 100 µm in length (yellow arrowheads) that
extended from the cell bodies (black arrows), as evidenced by SEM images (top panel). These 3D
substrates were also found to promote the expression of the osteogenic markers Osteocalcin (OCN) and
Osteopontin (OPN), as displayed by immunofluorescence images (bottom panel). (c) SEM images of the
rGO-coated Hap nanocomposites showing that Hydroxyapatite (HAp) particles were partly covered
and interconnected by an network of rGO nanosheets (top panel). ARS staining performed at 21 days
reveals that rGO-coated HAp nanocomposites significantly increase calcium deposits in MC3T3-E1
cells compared to the non-treated control and rGO or HAp alone (bottom panel). (d) Schematic
representation of the study: human BM-MSCs were seed d onto rGO substrates, then exposed to
Pulsed Electromagnetic Fields (PEMFs) (top panel). The rGO+PEMFs group exhibited the strongest
staining as videnced by ARS staining performed after 2 weeks from cells seeding. Reproduced with
permissions from [50,51,53,62].
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One last work worth mentioning is the one of Lim and colleagues [62]. The authors used
Pulsed Electromagnetic Fields (PEMFs) in combination with rGO substrates to evaluate the osteogenic
differentiation of human alveolar BM-MSCs. PEMFs therapy is based on the physical effect sorted
from the combination of an electric with a magnetic field, generating waves that propagate at the
speed of light; and it has already been reported to strongly enhance the commitment of ADSCs into
mature osteoblasts in vitro [63]. Cells cultured using osteogenic medium were exposed to 30 minutes
daily treatments of 0.6 ± 0.05 mT and 50 Hz PEMFs for up to 2 weeks. After 7 days, rGO+PEMFs
promoted the expression of ALP, an early marker of osteogenesis, whereas at week 2, the same scaffolds
stimulated OPN, OCN and Runt-related transcription factor 2 (RUNX2) expressions as well as calcium
deposition. In addition, DNA microarray analysis established that the combination of rGO and PEMFs
increased the expression of genes related to ECM formation, membrane proteins and metabolism.
The results of this work seem to demonstrate the synergic effects of rGO scaffolds and PEMFs on the
osteogenesis of human alveolar BM-MSCs (Figure 3d).
All the works presented in this section demonstrate that, over the last few years, graphene has been
found as one of the most promising biocompatible scaffolds for human MSCs adhesion, proliferation
and differentiation, particularly towards the osteogenic lineage. These recent investigations clearly
indicate a potential or active ability of graphene and its derivatives to induce the osteogenic
differentiation of MSCs. Graphene alone seems to drive the spontaneous osteogenesis of stem cells;
however, the presence of osteogenic inducers or growth factors in culture medium contributes in
promoting this effect. Further summarizing the studies presented here, we may conclude that the
association of graphene with stiff substrates, such as HAp, or with natural bone components, such as
collagen, enhances the intrinsic properties of graphene in guiding the osteogenic differentiation
of stem cells. Also mimicking the natural bone ECM, for example through the production of 3D
graphene-based scaffolds, has proved to be a novel strategy in directing the stem cell fate towards
the osteogenic lineage. Nevertheless, a deeper understanding of the ability of graphene to improve
the biological properties of different scaffold materials will be essential to engineer graphene-based
substrates for targeted biomedical applications.
Regarding stem cells of dental origin, few data are available to date. Dental tissues are a very
rich source of stem cells, which are collectively called Dental Stem Cells (DSCs) [9]. In the following
paragraphs, studies describing applications of graphene-based nanomaterials in association with DSCs
will be presented.
2.2.1. Dental Pulp Stem Cells (DPSCs)
Dental pulp is the soft connective tissue of the tooth and Dental Pulp Stem Cells (DPSCs) are a
unique MSCs population that is present in the cell rich zone and core of the pulp. These cells were
firstly discovered in 2000 by Gronthos and colleagues, thanks to their ability to differentiate into
odontoblasts/osteoblasts, adipocytes and neural-like cells [64].
Previous studies established that DPSCs and BM-MSCs are analogous cell populations, since they
share expression profile for thousands of genes, among which those associated with the initiation of
mineralization and bone homeostasis [65]. Other commonly expressed genes include those coding
for various growth factors known to be strong promoters of osteogenesis, such as Fibroblast Growth
Factor 2 (FGF-2) and Bone Morphogenetic Protein 2 (BMP-2) and BMP-4, but also genes encoding ECM
components such as ALP, Collagen type I (COLI) and OCN. Human dental pulp is an optimal source of
DPSCs due to its easy surgical access, the very low morbidity of the anatomical site after the collection
of the pulp and the high efficiency of the extraction procedure of the stem cells from the tissue [66].
In addition, compared to equal volumes of bone marrow, dental pulp contains a higher number of MSCs.
In the study of Rosa and coworkers, the effect of GO-based scaffolds on DPSCs proliferation
and differentiation was evaluated and compared to that of glass substrates [67]. Cell morphology
and proliferation were evaluated by SEM and fluorescence microscopy after 5 days from seeding;
mRNA expression of Msh homeobox 1 (MSX-1), Paired box 9 (PAX-9), RUNX2, COLI, Dentin Matrix
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acidic Phosphoprotein 1 (DMP-1) and Dentin Sialophosphoprotein (DSPP) genes was measured at
7 and 14 days. The results of this study indicated that DPSCs were able to adhere on both the glass and
GO surfaces, without any significant difference in proliferation. Nevertheless, when mRNA expression
levels were measured, these resulted significantly higher for all genes tested onto GO compared to
glass surfaces after 14 days from seeding (Figure 4a). MSX-1 is essential for the development of
teeth, craniofacial structures and/or limb structures in embryos; it is a target activator of PAX-9 and
the deletion of them causes tooth agenesis in mice [68,69]. RUNX2 is a transcription factor that is
essential for osteogenic differentiation and can up-regulate the expression of OCN [70]. DMP-1 is
highly expressed during odontogenesis and in mature odontoblasts, it is capable to produce dentin
in vivo and its deficiency leads to dentinogenesis imperfecta [71]. DSPP codes for two proteins, dentin
sialoprotein and dentin phosphoprotein, both of which have been associated with early dentinogenesis
and are absent in bone [72]. What is really considered interesting in this work is the fact that the GO
substrates provided an up-regulation for all the measured gene expression, even if no inducers for
differentiation were used. In addition, the substrate was also capable of increasing the expression of
both DMP-1 and DSPP, which are intimately related to odontogenic differentiation of stem cells from
dental pulp. This means that the use of GO substrates by themselves may enhance the expression of
odontogenic genes opening new opportunities to the use of GO alone or in combination with dental
materials to improve their bioactivity and beyond.
In another study, the authors aimed at evaluating the potential of graphene to induce odontoblastic
or osteogenic differentiation of DPSCs without the use of any chemical inducers [73]. Dentin and
bone are considerably made of a HAp that is associated with the matrix produced by odontoblasts
and osteoblasts, respectively [64]. Mineralization, odontogenic and osteogenic genes expression and
protein expression of RUNX2, COLI and OCN were evaluated in DPSCs seeded on graphene and glass
substrates for 14 and 28 days. Regarding the mineralization process, the graphene substrate positively
influenced the cells to spontaneously secrete mineralized matrix. When comparing the gene expression
levels, the odontoblastic-related genes MSX-1, PAX-6 and DMP-1 were significantly down-regulated
on graphene substrates compared to glass. On the contrary, graphene increased both gene and protein
expressions of RUNX2 and OCN, thus suggesting its ability to induce osteogenic differentiation rather
than odontogenic differentiation of DPSCs. An explanation to this may be the high Young modulus
of graphene (1.0–2.4 TPa) [74], which can contribute to the osteogenic differentiation of DPSCs as
these cells usually need soft substrates to achieve the odontogenic differentiation [75]. Taken together,
the results of this study suggest that DPSCs are not prone to differentiate into odontoblastic-like cells
when grown on graphene, but this substrate is able to induce osteogenic differentiation of the cells
without the use of chemical inducers for osteogenesis.
Therefore, authors seem to agree with the fact that graphene is a biocompatible material for
DPSCs and it might be used as a valid substrate for dental tissue engineering since it is able to promote
either osteogenic or odontogenic differentiation of DPSCs depending on the surface characteristics
and functionalization of graphene, as also emerged in the previous section.
2.2.2. Periodontal Ligament Stem Cells (PDLSCs)
The periodontium refers to those structures which surround and support teeth. It is composed by
four parts: gingiva, alveolar bone, cementum and periodontal ligament. The function of the periodontal
ligament is to literally attach the teeth to the bone and when a chronic process, called periodontitis,
affects these structures, the teeth stability and health are compromised. All the periodontium is
constantly maintained by Periodontal Ligament Stem Cells (PDLSCs), which have the ability to
differentiate into cementoblasts, odontoblasts and fibroblasts [76].
Thanks to their potential to differentiate into several types of specialized cells, PDLSCs can be used
as substitute to BM-MSCs in order to determine the osteogenic potential and the viability onto different
substrates [77]. Even if in literature the bone formation potential of PDLSCs on various surfaces such
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as Titanium (Ti) has been already demonstrated [78], few articles evaluated the biocompatibility of
graphene-based nanomaterials for human PDLSCs.
In one of the few studies, the effects of GO, Silk Fibroin (SF) and GO combined with SF were
investigated on PDLSCs adhesion, proliferation, viability and expression of MSCs markers [79].
SF is widely used as a biocompatible material in the fabrication of cellular scaffolds for tissue
engineering and a composite of the two materials has already been proposed for several biomedical
applications [80,81]. Nevertheless, its performance as a substrate for growing of PDLSCs has not
been addressed yet. In this work, PDLSCs obtained from healthy extracted molars were used and
cultured up to 10 days on the above-mentioned substrates and on plastic, which represented the control
condition. Cell adhesion was higher on GO and on the GO-SF composite film rather than on fibroin
alone, as revealed by immunofluorescence staining of the actin cytoskeleton (Figure 4b). Regarding
the cells proliferation rate, the results of the MTT assay showed a high rate of proliferation for PDLSCs
growing on GO films compared to plastic and on GO and fibroin composite film compared to fibroin
alone after 10 days from seeding. In order to evaluate if the biomaterials employed in this study
were able to maintain the mesenchymal phenotype of PDLSCs, flow cytometry was used to assess
the expression of some MSCs surface molecules. Culture of PDLSCs on SF, GO or GO-SF composite
did not significantly alter the level of expression of the typical MSCs markers CD73, CD90 or CD105
compared to expression levels displayed by PDLSCs cultured on plastic The authors concluded that
the GO-SF composite significantly improved the performance of the fibroin film, as an alternative to
the coating with collagen, representing an interesting combination of biocompatibility, induction of
proliferation and mechanical resistance, very suitable for working in cellular environments where
mechanical resistance is required.
Later, the same group investigated the potential of SF and GO composites to promote human
PDLSCs spontaneous differentiation into osteo/cementoblast-like cells [82]. In the study, the authors
have optimized the parameters of fabrication of the GO-SF composite film, using different ratios of the
two materials and also varying the graphene oxidation status, with the aim to find the best configuration
for cell proliferation and differentiation. The PDLSCs proliferation rate was consistently improved in
those combinations containing low amounts of graphene and a high SF dose, as emerged from the MTT
assay results at 7 and 10 days of culture. The authors concluded that the best configurations in terms of
PDLSCs proliferation were GO alone and rGO:rSF at 1:3 ratio. SF was used to confer 3D characteristics
to the GO or rGO as well as to improve its handling. Previous data have shown that human PDLSCs
bioengineered on 3D graphene scaffold preparations are associated with higher proliferation rates than
on 2D ones [83]. Flow cytometry analysis was further used to confirm the mesenchymal phenotype of
the isolated PDLSCs and to determine possible phenotypic changes after their culture on the different
graphene-fibroin combinations. The MSCs surface molecules CD73, CD90 and CD105 were found to be
present in the PDLSCs grown on all the biomaterials tested, although their expression decreased with
culturing time. This is not surprisingly, since the expression level of MSCs markers progressively declines
in stem cells during their multilineage differentiation process [84,85]. After demonstrating the beneficial
effects of GO-SF composites on PDLSCs proliferation, gene expression analyses were performed to further
characterize the effect of these scaffolds on PDLSCs differentiation into osteo/cementoblast-like cells.
No osteogenic chemical inducers were added to the culture medium. GO-SF composites, particularly
the reduced configurations rGO, rSF and rGO-rSF, were found to induce the over-expression of early
osteoblast/cementoblast markers, including BMP2, RUNX2, ALP and COLI. On the contrary, Osterix
(OSX) and Osteocalcin (OCN), whose expressions are associated with late osteoblast differentiation
stages, were found to be down-regulated on all the substrate preparations. Starting from this result,
the authors explored the expression of two specific cementum-related genes, Cementum Attachment
Protein (CAP) and Cementum Protein 1 (CEMP1), that are expressed at early and late differentiation
stages, respectively [86]. All the scaffolds tested were associated with significant down-regulation of
CAP and concomitant over-expression of CEMP1, suggesting that graphene-fibroin composites can
induce cementoblast differentiation of the human PDLSCs in the absence of any growth factors.
Nanomaterials 2018, 8, 349 12 of 31
2.2.3. Dental Follicle Progenitor Cells (DFPCs)
The dental follicle is the loose connective tissue surrounding the enamel organ and the dental
papilla of the developing tooth germ. Its principal role is the coordination of tooth eruption
through the regulation of the osteoclastogenesis and osteogenesis processes [87]. The Dental Follicle
Progenitor Cells (DFPCs) are multipotent stem cells that have immunomodulatory properties, high
proliferation rate and ability to differentiate into odontoblasts, cementoblasts, osteoblasts and other
cells implicated in the teeth [88]. Furthermore, they are able to re-create a new periodontal ligament
after in vivo implantation.
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Figure 4. Interactions of graphene-based nanomaterials with Dental Stem Cells (DSCs). (a) SEM images
showing that Dental Pulp Stem Cells (DPSCs) can efficiently adhere and proliferate on GO substrates
for 3 and 5 days (top panel). DPSCs on GO present higher expression compared to glass (control)
for all genes tested both at 7 and 14 days (bottom panel). (b) SEM images of films composed of Silk
Fibroin (SF), GO and GO-SF mixture (3:1) at different magnifications (top panel). Immunofluorescence
staining of the actin cytoskeleton showing a higher adhesion of Periodontal Ligament Stem Cells
(PDLSCs) on GO and on the GO-SF composite film rather than on SF alone at 7 days. (c) TEM images
of GO, Thermally Reduced Graphene Oxide (TRGO) and Nitrogen-doped graphene (N-Gr) (top panel).
Confocal microscopy images of human Dental Follicle Progenitor Cells (DFPCs) seeded on GO, TRGO
and N-Gr at 40 µg/mL showing staining of cytoskeleton actin filaments (green) and nuclei (red) (bottom
panel). Reproduced with permissions from [67,79,89].
To date, only one study evaluating the behavior of human DFSCs on graphene-based
nanomaterials has been reported [89]. In the work, human DFSCs obtained from healthy extracted teeth
were seeded onto GO, Thermally Reduced Graphene Oxide (TRGO) and Nitrogen-doped graphene
(N-Gr) substrates. Then, cytotoxicity, oxidative stress induction, cellular and mitochondrial membrane
alterations were analyzed for all the developed substrates (Figure 4c). The results of this study showed
that GO was the less toxic for the cells, followed by N-Gr, whereas the TRGO substrate resulted the
more toxic. Regarding the oxidative stress level, both the GO and the TRGO substrates induced lipid
peroxidation without significant alteration of the membrane. On the other hand, the N-Gr substrate,
which showed to have a positive antioxidant effect on the stem cells studied, reduced cell viability
without oxidative stress. The authors suggested that N-Gr affected the cells not only determining
a physical damage of the plasma membrane due to graphene irregularities, but also by the ability
of nitrogen to coordinate biomolecules thus interfering in the biological processes. As regards the
mitochondria membrane potential, it was decreased in all the substrates used in this study following
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a dose-dependent manner. This effect was higher in the TRGO than in the GO substrate, while in
the N-Gr substrate structural lesions were present only at high concentrations (20 and 40 µg/mL).
The authors concluded that while GO and N-Gr may be considered as promising fillers for various
dental nanocomposites, TRGO does not seem to be a suitable material.
2.3. Graphene and Immune Cells
A critical step for the application of nanotechnology in medicine is the interaction of a material
with the immune system because, once administrated, it immediately enters in contact with the immune
cells. Graphene and its composites are not exempt from the interaction with cells of the immune system
and, as in the last few years the biological applications of graphene-based nanomaterials have grown,
it results necessary to investigate the immune-related impact of these nanomaterials. Many papers
about this issue underlined stimulation or suppression effects of graphene-based nanomaterials
on immune system cells, depending mainly to graphene purity, oxidation level, shape dimension,
functionalization and to the type of immune cells analyzed.
The first extended investigation on graphene and immune cells was made by Sasidharan and
coworkers [37]. After comparing the effects of pristine graphene and GO on Peripheral Blood
Mononuclear Cells (PBMCs), the authors observed really different effects: pristine graphene induced a
significant release of Interleukin-8 (IL-8) and IL-6 whereas GO determined only a moderate release of
IL-8, despite both seemed to have an excellent compatibility with PBMCs.
To best characterize the impact of GO on immune cells, Orecchioni and colleagues studied and
compared the effects of small-size (100–500 nm) and large-size (1–10 µm) GO flakes on a pool of
PBMCs [90]. The authors detected a more efficient cellular activation and cytokine release by small-size
GO. In particular, through gene expression analysis, they underlined that small GO is able to modulate a
large number of genes related to cytokines and activation-related genes, such as T-box transcription factor
(TBX21) and CD80. Furthermore, it was found that GO promotes the over-expression of many pathways
such as leukocytes chemotaxis pathway and genes associated with C-X-C motif chemokine 10 (CXCL10)
ligand and C-X-C motif chemokine receptor 3 (CXCR3), able to activate T-helper and Natural Killer (NK)
cells. Once established various effects on the total PBMCs, several studies have then been performed also
analyzing the effect of graphene on specific immune cell types, as described in the following paragraphs.
2.3.1. Lymphocytes
Lymphocytes, which represent about the 20–40% of the white blood cells and the 70–80% of
PBMCs, are responsible for the antigen-specific and innate immune response. The most of research
have been made analyzing the effects of graphene-based nanomaterials on T lymphocytes, concluding
that the cytotoxicity of graphene depends on its dosage, time of exposure and type of material with
which these are combined. For example, Ding and coworkers demonstrated that low doses of GO have
no cytotoxic effects on T lymphocytes, while a dose over 100 µg/mL causes oxidative stress related
apoptosis after 24 h of incubation [91]. In particular, at high concentration GO was found absorbed on
cell membrane, without internalization or cell membrane disruption, but it caused a reduction of cell
viability and an increase of lymphocytes apoptosis probably due to the production of ROS. However,
no significant reduction in T lymphocytes immune response was found. The same tests conducted
on GO-polyethylenimine (GO-PEI) revealed that this kind of functionalization severely damaged T
lymphocytes and suppressed their immune ability [91]. On the contrary, the functionalization of GO
with polyvinylpyrrolidone (PVP) increased the biocompatibility of GO and at high doses of GO-PVP
the amount of apoptosis was much less then in GO alone [92].
2.3.2. Macrophages
Half of the studies about graphene and the immune system have been carried out on macrophages,
not only because these represent the first phase of body immune reaction, but also because macrophages
are the easiest long-term culturing primary immune cell population [93].
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The phagocytic activity of macrophages makes them the most exposed cells to the negative
influence of graphene and its derivatives [94]. It has been reported that the ability of macrophages to
the internalization mainly depends on the size of the sheets: the smaller is the lateral dimension of GO,
the greater the ability of macrophages to internalize it [95]. Moreover, the capacity of macrophages
to phagocyte GO can be modulated by GO functionalization. Zhi and colleagues demonstrated that
the functionalization of GO with PVP decreases the internalization of the compound, indicating that
PVP-GO has a better immunological biocompatibility (Figure 5a) [92].
Regarding the activation of macrophages, Chen and colleagues showed that pristine graphene and
GO promoted the production of several cytokines, such as IL-1α, IL-6, IL-10 and Tumor Necrosis Factor
alpha (TNF-α), via NF-κB pathway, that is activated via Toll-Like Receptors (TLRs) [96]. Graphene
promotes the activation of IκB Kinase (IKK), thereby activating NF-κB [97,98]. Moreover, GO stimulates
the production of Myeloid Differentiation primary response gene 88 (MyD88), another protein related to
TLRs. Activated TLRs start the kinase cascade, by a MyD88 mechanism, that promotes the translocation
of NF-κB into the nucleus, thus increasing cytokines gene expression (Figure 5b). In addition, an elevated
activation of TLRs, especially TLR-4, causes TLR-dependent necrosis of macrophages. The silencing
of genes that code for TLRs, completely immunize macrophages from graphene [99]. The stimulation
of TLRs also favors the formation of phagosomes that active enhance the uptake of graphene and the
consequent affection of cell metabolism and gene/protein expression [99]. Experiments on phagocytic
process showed that 100 µg/mL GO generate the same effects of LPS stimulation that is the activation
of macrophages and the production of pro inflammatory cytokine [100].
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Figure 5. Interactions of graphene with macrophages. (a) Optical micrographs of macrophages treated
with 25 µg/mL GO and PVP-GO for 48 h. Macrophages showed to be inclined to GO internalization
(red arrows), while the functionalization with PVP prevents the phenomenon. (b) Signaling pathway
of macrophage activation stimulated by graphene. Graphene may stimulate Toll-Like Receptors (TLRs),
thus activating kinase cascade Myeloid Differentiation primary response gene 88 (MyD88)-dependent
mechanism. IKK activation initiates the phosphorylation and degradation of IκB and consequently,
the release of NF-κB subunits and their translocation into the nucleus. NF-κB binds to the promoter
regions of its effector genes and initiates the transcription of multiple pro-inflammatory genes and the
secretion of Interleukin 1α (IL-1α), IL-6, IL-10, Tumor Necrosis Factor alpha (TNF-α). Reproduced with
permissions from [92,99].
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2.3.3. Dendritic Cells (DCs)
Dendritc cells (DCs), representing the 1–2% of PBMCs, play a fundamental role in the activation
of antigen-specific T lymphocytes [101]. Few data are available about interactions of graphene-based
nanomaterials and DCs. Tkach and coworkers showed that GO incorporated by DCs down-regulates
the intracellular level of LMP7, a part of an immunoproteasome required for processing protein
antigen [102]. In another study, Zhi and colleagues compared the effect of GO and PVP-GO on DCs,
highlighting a capacity of GO to promote maturation of DCs and also the overexpression of IL-6
in a dose-dependent manner, compared to the non-treated group [92]. The authors concluded that
functionalization with PVP mitigate the effects of GO, that resulting in a lower immunogenicity.
2.4. Graphene and Antibacterial Activity
Infection is a frequent process during biomaterial implantation procedures. Since antibiotics often
impact negatively on bacterial flora and pathogens are able to acquire resistance against different
antibiotics, in the last few years various nanotechnologies with antimicrobial properties have been
developed and studied [103,104], trying to get closer to the ideal scaffold that should inhibit bacterial
growth at the surface, while simultaneously promoting cell adhesion and proliferation [43].
It has been reported that some graphene-based nanomaterials possess antibacterial properties;
nevertheless, the effects of graphene on bacteria structure, metabolism and viability depend on
the materials’ concentration, time of exposure, physical-chemical properties, as well as on the
characteristics of bacteria used in the tests [105,106].
A lot of studies indicated that graphene and several graphene nanocomposites have a remarkable
antibacterial ability against both Gram-negative and Gram-positive bacteria [107–110]. It has been
demonstrated that the antibacterial effect is due to the capacity of graphene to physically damage
microorganisms through different mechanisms: graphene nanostructure acts as a nano-knife
penetrating and cutting cell membrane, it wraps cells inducing mechanical stress, it is able to extract
phospholipids from lipid membranes and it produces oxidative stress through ROS generation but also
by charge transfer phenomena. Molecular dynamic simulations suggest that thin graphene nanosheets
can insert into both bacterial membranes creating a break and, once inserted, the Van Der Walls forces
and the hydrophobic properties of graphene promote phospholipids extraction from the lipid layers of
the bacterial membranes causing irreversible damages [111].
Another way for graphene to exert antibacterial activity seems to be through the separation of
microorganisms from the microenvironment. Aggregated graphene sheets in suspension can isolate
bacteria from the surrounding environment hindering nutrient consumption, reducing their ability to
proliferate and favoring their inactivation [108].
Graphene antibacterial activity is also probably related to oxidative stress induction. This is
mainly mediated by ROS generation, especially when GO is used, nevertheless oxidative stress can be
triggered without ROS generation. Li and coworkers showed that graphene is able to act as an electron
pump pulling out electrons from bacterial membranes and inducing ROS-independent oxidative stress
that affects microorganisms [110].
Obviously, these mechanisms are not specific against bacteria but can also affect other cells,
although with less effectiveness. Pang and colleagues tried to clarify the ratio between biosafety
and antibacterial activity of graphene and GO [112]. They observed that both cytotoxicity and
antibacterial effects are dose-dependent and that GO has a higher activity; in particular, a GO
concentration in the range of 50–100 µg/mL keeps the balance between minor cytotoxic effects and
major antibacterial activity.
Among graphene derivatives, GO attracted particular attention thanks to the ease with which
it can be functionalized, representing the precursor of the most graphene nanocomposites, but also
thanks to its excellent water dispersity. However, a lot of study established that antibacterial activity
of GO is dependent not only on its concentration but also on the size and the lateral dimension of GO
sheets. Liu and colleagues demonstrated that the antibacterial activity of GO nanosheets depends on
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their size [113]. Indeed, larger GO sheets express stronger antibacterial activity against Escherichia coli
compared to smaller one, probably due to the capacity of larger GO sheets to completely cover bacteria
inhibiting their proliferation and colony formation (Figure 6a).
In the environment of the oral cavity, Streptococcus mutans, Porphyromonas gingivalis and
Fusobacterium nucleatum are the most representative bacteria responsible for caries, periodontal and
periapical diseases [114]. The microbial community resident in the mouth exists in balance with the oral
microenvironment [115]. Host susceptibility, diet and habits could lead to a break in balance that gives
rise to adverse reactions. In particular, S. mutans is a Gram-positive facultative anaerobic bacterium
importantly involved in caries formation and in the modification of the oral microenvironment,
decreasing the pH value by the production of large amount of organic acids [116]. Instead, P. gingivalis
and F. nucleatum are Gram-negative anaerobic bacteria, associated with periodontitis [117]. For these
reasons, antibacterial activity of graphene and its nanocomposites, in particular against these cariogenic
bacteria, has been studied. He and collaborators investigated the effect of GO against dental pathogen
bacteria, showing that the viability of S. mutans, P. gingivalis and F. nucleatum decreased in the presence
of GO nanosheets depending on its concentration in a dose-dependent manner [114]. TEM images
clearly showed that, when the GO was present, the integrity of S. mutans, P. gingivalis and F. nucleatum
was strongly compromised due to the severe insertion, cutting and destructive extraction of lipid
molecules effect that GO act against the membrane (Figure 6b).
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Figure 6. Effect of GO nanosheets on bacteria. (a) Atomic Force Microscopy (AFM) amplitude (top)
and 3D (bottom) images of Escherichia coli cells 2 h of after incubation with/without GO sheets. E. coli
cells incubated with deionized water without GO sheets show a preserved integrity of the membrane
(control). The incubation with the 40 µg/mL large GO sheets suspension results in a completely cover
of bacterium surface by GO sheets, whereas small GO sheets adhere to cell surface without fully
covering it. Scale bars are 1 µm. (b) TEM images of Streptococcus mutans, Fusobacterium nucleatum and
Porphyromonas gingivalis cells after incubation with GO nanosheets dispersion (right side) for 2 h and
after incubation with saline solution for 2 h as control (left side). All treated cases had the same GO
dose of 80 µg/mL. Scale bars are 500 nm. Reproduced with permissions from [113,114].
Graphene and some of its composites seem to exert their activity not only against single
bacteria but also against bacterial biofilms. Biofilms are surfaced-attached bacterial communities
that self-produce adhesive ECM; they play a role in a wide variety of infections, i.e., caries, catheter
infection and bloodstream infection [118]. Several complicated and expensive methods to prevent
biofilms formation have been proposed, including coating of nanomaterials with ion or polymers
impregnated with antibiotics [119–122]. Recently, inspired by graphene antibacterial ability and
its ease functionalization, possible effects of graphene-based nanomaterials against biofilms are
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being studied. For example, Song and coworkers investigated the influence of GO on bacterial
biofilm formation, observing that high GO concentrations inhibit the formation of Gram-negative
and Gram-positive biofilms via membrane stress, whereas low GO concentrations enhance their
formation [123]. The authors hypothesized that low GO concentration kills only a limited part of
bacteria and dead cells could serve as a protection barrier and nutrient to the rest of biofilm formation,
whereas high GO concentration promotes the inactivation of most bacteria, hindering the biofilm
growth. In another work, Mao and colleagues tested the antibiofilm activity of a GO-aptamer composite
and compared to that of GO and aptamers per se [124]. They showed that all agents interacted with
pathogen disturbing the initial growth of biofilm and destroying the established biofilm, but the
combination of GO and aptamers exhibited a superior synergic effect than the single substances.
Despite a lot of studies stressed an antimicrobial activity for pristine graphene and GO, some other
works evidenced that graphene has no intrinsic bactericidal properties, but even it is able to enhance
bacteria growth when a colloidal suspension is formed [125,126]. Das and Ruiz in their studies showed
that only the functionalization with antibacterial agents such as silver nanoparticles conferred to the
graphene-based nanomaterials a bactericidal activity [125,126]. In agreement with these studies, Some and
collaborators confirmed that graphene alone has no antibacterial properties, but graphene-iodide
composites, above all double-oxidizes GO-iodide, have a potent antibacterial activity [127].
Wu and coworkers tried to clarify the debate concerning the antimicrobial activity of graphene
and its derivatives comparing the antibacterial effects of GO, GO-polyoxyalkyleneamine (GO-POAA)
and GO-chitosan against E. coli and Bacillus subtilis, Gram-negative and Gram-positive bacteria,
respectively [128]. The results of this study indicated that less than 50 µg/mL GO in a nutrient
medium solution has no antimicrobial activity; on the contrary, it enhances bacterial growth acting as
a biofilm that allows bacterial attachment and proliferation. On the other hand, the conjugation of GO
with POAA or chitosan, two antibacterial molecules, at the same concentration showed antibacterial
effects. All materials demonstrated antibacterial activity when bacteria were grown in Phosphate
Buffered Saline (PBS) solution.
All these studies would suggest that the antibacterial activity of graphene-based nanomaterials is
variable and dependent on the conditions of the tests; in particular, results change depending on the
type of material and the size of particles, on its concentration and its state (in solution or adsorbed on
a support), on the type of bacteria used in the study and on the medium used for their growth.
3. Applications of Graphene-Based Nanomaterials in the Dental Field
Graphene and its derivatives display many potential applications in the dental field, as can be seen
from the literature. Thanks to their potentiality, particularly in driving the osteogenic differentiation
of stem cells and antibacterial abilities, the application of graphene-based nanomaterials to already
existing dental technologies are being studied. In addition, graphene seems to be interesting as
a platform able to release therapeutic molecules to improve implants osseointegration and bone
formation. In the following paragraphs, we will present several studies discussing the association
of graphene with dental implants, membranes, resins, cements and adhesives, as well as strategies
for teeth-whitening.
3.1. Graphene and Dental Implants
Nowadays, Ti dental implants are considered as the best substitutes for missing teeth
thanks to their reliability and predictability, besides to their mechanical strength and favorable
biocompatibility [129,130]. Since these devices are in close contact with the surrounding tissues,
a critical parameter for the success of the implantation is the ability of the implant to integrate with the
tissue promoting the osseointegration process; this represents indeed a fundamental step for obtaining
the best new bone quantity and quality [129,131]. During this process, a key role is played by the
implant surface characteristics such as roughness, surface treatment and hydrophilicity.
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Ti inertness represents a disadvantage because it may induce the development of fibrous tissue
which could lead to the failure of the implant [130]. For this reason, several studies have focused on
modifying implant surfaces to favor a better osseointegration. In this context, graphene appeared to be
an excellent implant-coating for hard tissue engineering in order to accelerate bone regeneration.
As evidenced earlier, GO-coating was found to be a successful substrate for anchoring and growing
of DPSCs on its rough surface and for promoting their osteogenic differentiation through up-regulation
of MSX-1, PAX-9, RUNX2, COLI, DMP-1 and DPSS in particular after 14 days of culture [67]. To improve
stem cells osteogenic differentiation, the groups of Jung and Ren functionalized GO-Ti implants using
different methods with dexamethasone, a synthetic glucocorticoid that is known to contribute to this
phenomenon [130,132]. Independently of the method of functionalization and coating, both groups
showed that GO-coating of Ti implants, even more when functionalized with dexamethasone, improves
implants biocompatibility, cell proliferation and mostly cell osteogenic differentiation.
Another approach to improve the osseointegration of Ti implants could be its coating with
bioactive proteins. For bone regeneration, BMP are the most potent osteoinductive proteins and
among these, BMP-2 has been reported to induce osteogenic differentiation of stem cells, which can
enhance the osseointegration of implants by forming bone at the space between the implants and the
implantation site [133,134]. La and collaborators investigated the efficiency of a Ti substrate coated
with GO as a delivery carrier for BMP-2, an osteoinductive protein that need to be released over a
long time period and Substance P (SP), a stem cells recruiter protein [135], for bone regeneration [136].
In vitro experiments showed that no significant difference was found in SP release between Ti and
Ti/GO. Interestingly, the BMP-2 release from the Ti/GO substrate was maintained for 14 days; on the
contrary, the release of almost all the BMP-2 content from the Ti substrate occurred on the first day.
Furthermore, the bioactivity of the BMP-2 released from the substrate was significantly higher in
the GO-coated group. The in vivo study, in which the different substrates were implanted on mouse
calvaria, showed that even if no significant difference in bone formation was found between Ti/BMP-2
and Ti/SP/BMP-2, Ti/GO/SP/BMP-2 implants showed much more extensive bone formation than
Ti/GO/BMP-2 implants confirming that the presence of GO preserves the bioactivity of proteins
(Figure 7).
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Figure 7. Bone regeneration of Ti implants with or without GO coating and BMP-2/SP loading in
mouse calvarial defects 8 weeks after treatment. The red arrowheads indicate the newly formed bone,
the black arrowheads indicate the implant at (a) 12.5× magnification and (b) 100× magnification.
Reproduced with permissions from [136].
Implant GO-coating represents an advantage also due to its antibacterial properties. Despite the
fixation of graphene on Ti implant makes it to lose a bit of antibacterial activity, there is the possibility
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to functionalize the coating with antibacterial substances, such as antibiotics or silver nanoparticles.
As demonstrated by Quian and colleagues, minocycline hydrochloride added to GO-coating improved
the antibacterial activity against aerobic or facultative anaerobic bacteria (Staphylococcus aureus),
facultative anaerobic bacteria (E. coli) and anaerobic bacteria (S. mutans) thanks to the synergic effect
of GO contact-killing and minocycline release-killing [137]. In another study, the group of Jianfeng
tested the antimicrobial activity of GO-silver coating on Ti, showing that it is very prominent against
S. mutans and P. gingivalis [138]. This suggests that this multiphase nanocomposite could be helpful in
the prevention of implant-associated infection.
As previously reported, human PDLSCs are promising DSCs that can be used as an alternative to
human BM-MSCs and GO is believed to be a useful platform for modulating structure and function of
these cells. Nevertheless, the behavior of PDLSCs on GO-coated Ti substrates is not fully understood.
In the work of Zhou and colleagues, the morphology, proliferation and osteogenic differentiation
potential of PDLSCs seeded on GO-Ti scaffolds were evaluated and compared to those obtained
on sodium titanate (Na-Ti) substrates [139]. The results of this study showed that, when the cells
were seeded onto GO-coated Ti scaffolds, they exhibited higher proliferation rate, ALP activity
and up-regulation of gene expression levels of the osteogenesis-related markers COLI, ALP, Bone
Sialoprotein (BSP), RUNX2 and OCN respect to those cultured on the Na-Ti substrate. In addition,
GO enhanced the expression of RUNX2, BSP and OCN also at a protein level. The authors concluded
that the combination of GO, PDLSCs and Na-Ti can represent a big step forward in regenerative
dentistry. Nevertheless, further additional studies will be necessary to elucidate how to use GO as
a biocompatible and implantable platform for the delivery of therapeutic proteins for applications
related to regenerative medicine, especially for the success of Ti dental implants.
3.2. Graphene and Membranes
To increase efficiency of bone repair, especially in periodontal and periimplant bone defects,
the use of Guided Bone Regeneration (GBR) membranes has been important for years in oral surgery.
These membranes are placed on the bone defect regeneration site and their principal function is
to not allow infiltration of soft tissue cells into the growing bone. Thus, these act as physical
barriers that separate connective tissue and the regenerating bone providing the slow osteogenic
cells migration [140]. In the dental field, the use of membrane for GBR was introduced in 1980’ to stop
cell migration from gingival connective tissue and epithelium to periodontal defect [141]. In the last
decades, several types of membrane, non-resorbable and bioabsorbable, have been developed and
tested for the application in GBR (Table 1) [142].
Table 1. Examples of different types of membrane used for Guided Bone Regeneration (GBR).
Type Name Materials Characteristics
Non-resorbable
Gore-Tex Expandedpolytetrafluoroethylene Good space maintainer, handling
Gore-Tex-Ti Titanium-reinforcedpolytetrafluoroethylene
Ideal for ridge augmentation and
grafting in bone defects
Resorbable natural
Tutodent Collagen Type I from bovinepericardium Resorbable rate: 8–16 weeks
Osseoguard Flex Collagen Type I and III frombovine dermis Resorbable rate: 6–9 months
Resorbable synthetic
Epi-Guide Poly-D,L-lactic acid Resorbable rate: 6–12 months
ResolutAdapt Poly-D,L-lactide/Co-glycolide Resorbable rate: 5–6 months,good space maintainer
All membranes need to satisfy the five main criteria underlined by Scantlebury: biocompatibility,
space-making, cell-occlusiveness, tissue integration and clinical manageability [143]. In order to
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improve these main criteria, graphene started recently to be used in this field. For example, De Marco
and colleagues enriched collagen membranes with two different concentration of GO (2 µg/mL
and 10 µg/mL) and tested the effect on Human Gingival Fibroblasts (HGFs) [144]. They showed
that the presence of GO on collagen membranes altered membrane features: it conferred a lower
deformability, higher stiffness and reduced hydration and increased roughness compared to non-coated
membranes. These changes favored the proliferation of HGFs, avoiding any inflammatory response,
as demonstrated by the reduction of IL-6 and Prostaglandin E2 (PGE2) secretion after 3 days of culture
and facilitated proteins adhesion to the membrane (Figure 8a).
The same GO-coating applied on collagen membranes was tested using DPSCs to analyze
osteoblastic differentiation and inflammatory response [145]. The researchers found that GO-coating
significantly increased cell viability on a concentration-dependent manner and promoted DPSCs
osteoblastic differentiation, as demonstrated by the up-regulation of BMP-2, RUNX2 and OSX gene
expression. Moreover, 10 µg/mL GO enrichment reduced the expression of TNF-α at all experimental
times compared to the control membrane, whereas 2 µg/mL GO enrichment significantly decreased
TNF-α expression only after 21 days of culture. Interestingly, Hematoxylin-Eosin staining revealed
that cells were not able to penetrate into the membrane and the more concentrated GO coating led
to the formation of a thicker cell layer (Figure 8b). The authors concluded that the GO enrichment of
collagen membranes promoted osteoblastic differentiation process, decreased inflammation and was
compatible with cell viability in a dose-dependent manner. These new membranes could be considered
as a valid alternative to substitute conventional collagen membranes.
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One of the main limitation of GNPs in dental application is its grey color. In order to ameliorate 
this aspect, Zanni and colleagues tested a hybrid material composed by Zinc Oxide Nanorods (ZnO-
NRs) grown on GNPs, thus combining the antimicrobial effect of GNPs with the light color and 
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3.3. Graphene and Resins, Cements and Adhesives
Resins, cements and adhesives are the most used materials for dental restoration. Nevertheless,
their porosity and adhesiveness make them receptacles for bacteria in the oral cavity and in particular
in proximity of dental restoration. These polymeric materials, indeed, facilitate the adhesion of
bacteria and the formation of biofilms that are the main cause of dental restoration failure [146].
An example of the application of graphene to dental commercial materials is reported in the study of
Bregnocchi and coworkers [146]. The authors added Graphene Nanoplatelets (GNPs) as nanofiller
to a commercial dental adhesive. The generated graphene nanocomposite significantly inhibited the
growth of S. mutans, without altering the standard adhesion properties of the dental adhesive.
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One of the main limitation of GNPs in dental application is its grey color. In order to ameliorate this
aspect, Zanni and colleagues tested a hybrid material composed by Zinc Oxide Nanorods (ZnO-NRs)
grown on GNPs, thus combining the antimicrobial effect of GNPs with the light color and biocidal
properties of ZnO-NRs [147]. The authors studied the effect of Zinc Oxide Nanorods-Decorated
Graphene Nanoplatelets (ZNGs) against S. mutans. The results showed that up to the 95% S. mutans
cell viability reduction was obtained using ZNGs even at a very low concentration (5 µg/mL).
Moreover, the biomass and exopolysaccharide production, which are necessary for the biofilm
formation, were evaluated: the ZNGs showed to behave as an obstacle for the biofilm growth.
The authors concluded that the use of ZNGs is a viable instrument to control caries disease as it
decreases S. mutans growth.
Biris and colleagues successfully prepared graphene sheets embedded with various amounts of
gold nanoparticles (Gr-Au-x) using the radiofrequency catalytic chemical vapor deposition technique
over a Aux/MgO catalyst [148]. Sarosi and colleagues analyze the effect of these sheets used
as nanofiller for some dental nanocomposites based on BisGMA/triethyleneglicol dimethacrylate
matrix [149]. The authors concluded that the graphene–gold nanoparticles could be very promising
filler for the dental nanocomposites because the reinforcement with high percent of nanoparticles is a
good solution to improve physicochemical properties.
As a last example, Li and collaborators demonstrated that the functionalization of glass ionomer
cements with fluorinated graphene is not only useful to inhibit bacterial growth but also to ameliorate
mechanical properties of the cements, increasing microhardness and compressive strength and
decreasing friction coefficient, all important parameters for cements [150].
3.4. Graphene and Teeth-Whitening
Nowadays, a lot of people would change the color of their teeth, which often is ruined by food,
beverage and smoke; consequently, the level of demand for tooth-whitening is increasing. Tooth color
is determined by intrinsic factors, associated with the light scattering and absorption properties of the
enamel and dentine and extrinsic factors, associated with the absorption of materials (e.g., tea, red
wine) on the surface of the enamel.
The products used for tooth-whitening are extensively-based upon Hydrogen Peroxide (H2O2)
chemistry, because of its bleach-properties and the techniques constantly evolve to ameliorate the rate
of whitening, the ease of the treatment and to decrease the side effects. The most common risks of
teeth-whitening include increase dental sensitivity and gingival irritation, besides changes in tooth
microstructure. These effects are directly related to the concentration of H2O2, the duration of the
treatment and the non-bleach component of the products [151].
To improve the bleaching process and decrease the time of the treatment, the light-activation
of peroxide-based products is used, but novel ways are being found to ameliorate the efficiency
of teeth-whitening. Several studies reported that the use of activating agents, such as nanoHAp
or Fe(III) phthalocyanine, together with H2O2 is useful for the purpose [152]. Based on these
evidences, Su and coworkers proposed the application of a nanocomposite made of rGO and Cobalt
Tetraphenylporphyrin (CoTPP) as a catalyst for tooth bleaching (Figure 9a) [120]. They then evaluated
its efficacy on tooth-whitening compared to the whitelight irradiation and D&C Red 34 or Orange
No. 4, two representative stain solutions. They concluded that the use of H2O2 plus CoTPP/rGO under
photoactivation increased the whitening effect of H2O2 and decreased the treatment time (Figure 9b).
This result might be explained because the active radicals produced by H2O2 have a short life and
so their main effect is to penetrate the tooth structure and then start a radical generation mechanism.
When photoirradiation is used, radical generation can be started deeper in the structure. Moreover,
photoactivating H2O2 plus CoTPP/rGO increase the reactions between H2O2 and stain molecules.
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Figure 9. Strategies based on graphene for improving teeth-whitening. (a) A schematic diagram
illustrating the enhanced peroxidase-like catalytic activity of the rGO-Co. Reactions of Cobalt
Tetraphenylporphyrin (CoTPP) with Hydrogen Peroxide (H2O2): CoIII TPP–e21(1/2) H2O2 → (CoIV)
TPP-OH2 (CoIV) TPP-OH→ 2 CoIII TPP1O212H1. (b) Photographs of teeth stained with dye D&C Red
34 and bleached using H2O2 alone or H2O2 plus CoTPP/RGO for 0.5 (left) or 70 h (right). Reproduced
with permissions of [150].
4. Limitations on the Use of Graphene
While graphene is one of the most promising materials in nanotechnology, the synthesis on
large scale represents an important aspect to be evaluated. Most of the studies described so far have
been carried out using small amount of uncontaminated and controlled defect-free samples [153],
but in the perspective of using graphene for applications on large scale, defects generated during the
production process need to be investigated. Various types of defects can generate spontaneously and
their formation is difficult to predict; they depend greatly on the method used for the production [154].
Defects change electronic structure, susceptibility and reactivity of graphene and its derivatives [155].
Most of the production techniques lead to the formation of graphene mixture, that differ in size, shape
and number of layer and are often contaminated with hydrocarbons or organic molecules which
alter the integration and the compatibility with cells and tissues [153]. These evidences represent a
substantial limitation on the study and use of graphene and graphene-based nanomaterials.
Another limitation on graphene biomedical application is the scarce existing information on
in vivo toxicity mechanisms and more studies are needed to support safe biological applications
of these materials. However, some reports showed that graphene-based nanomaterials mainly
accumulate in liver, spleen and lung after intravenous administration [43]. Few studies focused on
graphene-based nanomaterials elimination half-life indicating that small-sized nanomaterials present
fast elimination [45,156], but further work is needed. In addition, because of its recent discovery, little
is known about long-term toxicity of graphene and its derivatives and this issue represents a restriction
for clinical approaches.
Therefore, the scarce synthetic control, the high variability in production and the multiple
parameters that modulate activity and toxicity of graphene and graphene-based nanomaterials,
together with the scarce available studies, are big limitations for large scale application of graphene
and its derivatives.
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5. Conclusions and Future Perspectives
The research on biomedical applications of graphene-based nanomaterials has seen dramatic
progress in the last few years. In this review, we focused on the recent advances in dental tissue
engineering using graphene and its related nanomaterials. Graphene exhibits numerous outstanding
properties. In addition to its exceptional mechanical strength, electrical conductivity and thermal
stability, what makes graphene extremely interesting is the possibility to functionalize and combine it
with different biomaterials and biomolecules. This confers new properties to existing materials and
allows the generation of nanocomposites with enhanced characteristics.
In this review, we discussed recent studies concerning the biocompatibility, cytotoxicity and
antibacterial activity of graphene-based nanomaterials both in vitro and in vivo. Then, we analyzed
the effect of graphene-based nanomaterials on the adhesion, proliferation and differentiation of stem
cells, focusing in particular on stem cells of dental origin. We examined the potential of graphene to
promote osteogenic differentiation of stem cells, which is a key point for its future application in dental
field. In this context, we presented recent studies employing graphene and its related nanomaterials for
surface modification of dental implants or other scaffolds used in dentistry, such as membranes, resins
and adhesives. As clearly highlighted in this review, graphene-based nanomaterials have emerged
as promising scaffolds for a wide range of biomedical applications and all the presented works seem
to agree with the fact that existing dental materials show improved characteristics following the
addition of graphene; nevertheless, their behavior is closely dependent on graphene’s physicochemical
properties, such as surface functionalization, coating and size.
The increased interest in graphene and its derivatives have led to concerns about the risk of
exposure not only to humans but also to the environment. Therefore, evaluation of the safety and
potential risks of these nanomaterials is mandatory to ensure the safe use of graphene materials in
biomedical applications. However, there is still much investigation to perform in order to assess the
potential long-term toxicity of graphene and its composites and their effects on different cells, tissues
and organs, including those of oral cavity. Moreover, in-depth studies are necessary to understand
cell-signaling, metabolic pathways and osteogenic effects triggered by graphene-based nanomaterials.
Overall, we believe that the use of graphene-based nanomaterials in the dental field deserves to be
deeply explored as it can lead to even more reliable dental treatments in the near future.
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